350 related articles for article (PubMed ID: 31419461)
21. Tacrolimus-loaded nanostructured lipid carriers for oral delivery-in vivo bioavailability enhancement.
Khan S; Shaharyar M; Fazil M; Hassan MQ; Baboota S; Ali J
Eur J Pharm Biopharm; 2016 Dec; 109():149-157. PubMed ID: 27793753
[TBL] [Abstract][Full Text] [Related]
22. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
Noor NM; Sheikh K; Somavarapu S; Taylor KMG
Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
[TBL] [Abstract][Full Text] [Related]
23. Development of nanostructured lipid carriers containing salicyclic acid for dermal use based on the Quality by Design method.
Kovács A; Berkó S; Csányi E; Csóka I
Eur J Pharm Sci; 2017 Mar; 99():246-257. PubMed ID: 28012940
[TBL] [Abstract][Full Text] [Related]
24. Polymeric micelle nanocarriers for the cutaneous delivery of tacrolimus: a targeted approach for the treatment of psoriasis.
Lapteva M; Mondon K; Möller M; Gurny R; Kalia YN
Mol Pharm; 2014 Sep; 11(9):2989-3001. PubMed ID: 25057896
[TBL] [Abstract][Full Text] [Related]
25. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
Soni K; Rizwanullah M; Kohli K
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
[TBL] [Abstract][Full Text] [Related]
26. Nanostructured lipid carriers for site-specific drug delivery.
Khosa A; Reddi S; Saha RN
Biomed Pharmacother; 2018 Jul; 103():598-613. PubMed ID: 29677547
[TBL] [Abstract][Full Text] [Related]
27. Tadalafil-loaded nanostructured lipid carriers using permeation enhancers.
Baek JS; Pham CV; Myung CS; Cho CW
Int J Pharm; 2015 Nov; 495(2):701-9. PubMed ID: 26423175
[TBL] [Abstract][Full Text] [Related]
28. Selection and characterization of suitable lipid excipients for use in the manufacture of didanosine-loaded solid lipid nanoparticles and nanostructured lipid carriers.
Kasongo KW; Pardeike J; Müller RH; Walker RB
J Pharm Sci; 2011 Dec; 100(12):5185-96. PubMed ID: 22020815
[TBL] [Abstract][Full Text] [Related]
29. Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation.
Mennini N; Cirri M; Maestrelli F; Mura P
Int J Pharm; 2016 Dec; 515(1-2):684-691. PubMed ID: 27825863
[TBL] [Abstract][Full Text] [Related]
30. Development and characterization of nanostructured lipid carrier-based gels for the transdermal delivery of donepezil.
Mendes IT; Ruela ALM; Carvalho FC; Freitas JTJ; Bonfilio R; Pereira GR
Colloids Surf B Biointerfaces; 2019 May; 177():274-281. PubMed ID: 30763792
[TBL] [Abstract][Full Text] [Related]
31. Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery.
Cirri M; Bragagni M; Mennini N; Mura P
Eur J Pharm Biopharm; 2012 Jan; 80(1):46-53. PubMed ID: 21839833
[TBL] [Abstract][Full Text] [Related]
32. Nanostructured lipid carriers based nanogel for meloxicam delivery: mechanistic, in-vivo and stability evaluation.
Khurana S; Jain NK; Bedi PM
Drug Dev Ind Pharm; 2015; 41(8):1368-75. PubMed ID: 25151872
[TBL] [Abstract][Full Text] [Related]
33. Application of Statistical Tooling Techniques for Designing of Carvedilol Nanolipid Transferosomes and its Dermatopharmacokinetic and Pharmacodynamic Studies.
Selvaraj BR; Sridhar SK; Kesavan BR; Palagati S
Pharm Nanotechnol; 2020; 8(6):452-470. PubMed ID: 32988361
[TBL] [Abstract][Full Text] [Related]
34. A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers.
Pinto MF; Moura CC; Nunes C; Segundo MA; Costa Lima SA; Reis S
Int J Pharm; 2014 Dec; 477(1-2):519-26. PubMed ID: 25445970
[TBL] [Abstract][Full Text] [Related]
35. A synergistic approach of adapalene-loaded nanostructured lipid carriers, and vitamin C co-administration for treating acne.
Jain A; Garg NK; Jain A; Kesharwani P; Jain AK; Nirbhavane P; Tyagi RK
Drug Dev Ind Pharm; 2016; 42(6):897-905. PubMed ID: 26577703
[TBL] [Abstract][Full Text] [Related]
36. QbD guided early pharmaceutical development study: Production of lipid nanoparticles by high pressure homogenization for skin cancer treatment.
Amasya G; Aksu B; Badilli U; Onay-Besikci A; Tarimci N
Int J Pharm; 2019 May; 563():110-121. PubMed ID: 30935913
[TBL] [Abstract][Full Text] [Related]
37. Clobetasol-loaded nanostructured lipid carriers for epidermal targeting.
Silva LA; Andrade LM; de Sá FA; Marreto RN; Lima EM; Gratieri T; Taveira SF
J Pharm Pharmacol; 2016 Jun; 68(6):742-50. PubMed ID: 27061573
[TBL] [Abstract][Full Text] [Related]
38. [Preparation of isopsoralen loaded nanostructured carrier and its in vitro transdermal permeation characteristics].
Pang JY; Liu X; Shen BD; Shen CY; Lian WQ; Liu J; Hu CX; Zhong RN; Xu RC; Yuan HL
Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2473-2478. PubMed ID: 28840686
[TBL] [Abstract][Full Text] [Related]
39. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
Li H; Chen M; Su Z; Sun M; Ping Q
Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
[TBL] [Abstract][Full Text] [Related]
40. Novel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent Tamibarotene: characterization and evaluation.
Liu X; Zhang Z; Jiang Y; Hu Y; Wang Z; Liu J; Feng R; Zhang J; Huang G
Drug Deliv; 2015 Feb; 22(2):223-9. PubMed ID: 24559497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
